Adjuvant chemotherapy versus chemoradiation in high‐risk pancreatic adenocarcinoma: A propensity score‐matched analysis

PURPOSE: The American Society of Clinical Oncology guidelines recommend adjuvant chemoradiation (ACR) for margin‐positive (R1) and/or node‐positive (N+) pancreatic cancers. Our goal was to investigate if there is evidence of superiority of adjuvant chemoradiation (ACR) over adjuvant chemotherapy (AC...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Raoof, Mustafa, Blakely, Andrew M., Melstrom, Laleh G., Lee, Byrne, Warner, Susanne G., Chung, Vincent, Singh, Gagandeep, Chen, Yi‐Jen, Fong, Yuman
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2019
Témata:
Clinical Cancer Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6792522/
https://ncbi.nlm.nih.gov/pubmed/31414566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2491
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky